Canaccord Genuity downgraded Akumin from Buy to Speculative Buy and set a new price target of $3.00 from $3.50 previously

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/  PLANTATION, Fla., Jan. 31, 2024 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC Pink Open Market: AKUMQ) announced today that its previously announced restructuring transaction involving Stonepeak as well as its bondholders, lenders, shareholders and other stakeholders under a prepackaged chapter 11 plan of reorganization (the "Prepackaged Plan") is expected to become effective on or around February 6, 2024 (the "Effective Date"), subject to satisfaction of all of the remaining conditions to the closing of the restructuring transaction. On

PLANTATION, Fla., Aug. 9, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended June 30, 2023. Second Quarter 2023 Highlights Akumin delivered second quarter same-store volume performance on a consolidated basis as follows:+3.1% for MRI+16.5% for PET/CT+3.4% for Oncology Patient StartsThe Company reported revenue totaling $184.8 million for the second quarter, a $7.3 million or 4% decrease over the second quarter of last year.

PLANTATION, Fla., Aug. 8, 2023 /PRNewswire/ - Akumin Inc. (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, Thursday, August 10, 2023, to discuss its second quarter 2023 financial results.  The financial results are expected to be available on Wednesday, August 9, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q2-2023-Results-Dial-In-Numbers or via webcast at https://akum.in/Q2-2023-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call

PLANTATION, Fla., May 10, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended March 31, 2023. First Quarter 2023 Highlights Akumin delivered first quarter same-store volume performance on a consolidated basis as follows:+4.0% for MRI+16.1% for PET/CT+7.6% for Oncology Patient StartsThe Company reported revenue totaling $187.6 million for the first quarter, a $1.3 million or 1% increase over the first quarter of last year.Net

PLANTATION, Fla., May 4, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, May 11, 2023, to discuss its first quarter 2023 financial results.  The financial results are expected to be available on Wednesday, May 10, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q1-2023-Results-Dial-In-Numbers or via webcast at https://akum.in/Q1-2023-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to

PLANTATION, Fla., March 16, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter and year ended December 31, 2022. Fourth Quarter 2022 Highlights Akumin delivered fourth quarter same-store volume performance on a consolidated, pro forma basis as follows:-0.3% for MRI+7.8% for PET/CT+8.0% for Oncology Patient StartsThe Company reported revenue totaling $184.6 million for the fourth quarter, a $5.2 million or 3% increase over the fou

PLANTATION, Fla., March 10, 2023 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, March 17, 2023, to discuss its year-end 2022 financial results.  The financial results are expected to be available on Thursday, March 16, 2023. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/2022-YearEndResults-Audio or via webcast at https://akum.in/2022-YearEndResults-Webcast. A related presentation will be available from Akumin's website (www.akumin.com).  Participants are asked to connect at least 10 minutes prior to the beginning of the call to

PLANTATION, Fla., Nov. 9, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Highlights Akumin's radiology business delivered third quarter same-store volume performance on a consolidated, pro forma basis assuming the Company's acquisition of Alliance HealthCare Services was completed as of January 1, 2021:+0.2% for MRI+7.8% for PET/CT(2.5%) for Total Radiology Procedures(0.2%) for Onco

PLANTATION, Fla., Nov. 3, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, November 10, 2022, to discuss its third quarter 2022 financial results.  The financial results are expected to be available on Wednesday, November 9, 2022. To access the conference call, participants may join by using an appropriate dial-in number available through https://akum.in/Q3-2022-Results-Audio or via webcast at https://akum.in/Q3-2022-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to

PLANTATION, Fla., Aug. 9, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups with comprehensive solutions addressing outsourced radiology and oncology service line needs, announced today its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Highlights Akumin's radiology business delivered strong quarterly same store volume performance on a consolidated pro forma basis, which assumes the Company's acquisition of Alliance HealthCare Services, Inc. ("Alliance") was completed as of January 1, 2021:+2.0% for MRI+6.4% for PET/CT+4.5% for Total Radiology Pro

PLANTATION, Fla., Dec. 29, 2023 /CNW/ - Akumin Inc. (together with its subsidiaries, "we", "us", "our," "Akumin" or the "Company") (TSX:AKU) (OTC Pink Open Market: AKUMQ) announced today that its Board of Directors has appointed Ronald J. Bienias, Akumin's Chief Restructuring Officer and Partner and Managing Director of AlixPartners, LLP, as Interim Chief Financial Officer, effective today. He will also maintain his current role as Chief Restructuring Officer. Ronald's appointment follows the resignation of David Kretschmer, as Akumin's Chief Financial Officer effective today. Ronald has more than 20 years of experience serving in interim leadership roles or as an advisor at both large and

PLANTATION, Fla., Aug. 9, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) announced today that it has changed its auditor from Ernst & Young LLP ("EY") to Deloitte & Touche LLP ("Deloitte"). Effective as of August 9, 2023, the audit committee (the "Audit Committee") of the board of directors (the "Board") of the Company dismissed EY as the Company's independent registered public accounting firm. EY audited the Company's financial statements for each of the past two fiscal years ended December 31, 2022 and 2021, and EY's reports did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or

PLANTATION, Fla., June 12, 2023 /CNW/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023. Krishna has valuable experience and exceptional insight into the radiology space, having served as Senior Vice President & Business Leader - Precision Diagnosis at Philips North America, where he built a top performing team and business, over the last four years. Prior to this role, he led global businesses in Pathology, Oncology and Neuro at Philips based in Amsterdam, Netherlands from 2015-2019 and prior thereto was the CEO of Philips India. Before joini

PLANTATION, Fla., June 12, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ:AKU) (TSX:AKU) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023. Krishna has valuable experience and exceptional insight into the radiology space, having served as Senior Vice President & Business Leader - Precision Diagnosis at Philips North America, where he built a top performing team and business, over the last four years. Prior to this role, he led global businesses in Pathology, Oncology and Neuro at Philips based in Amsterdam, Netherlands from 2015-2019 and prior thereto was the CEO of Philips India. Befor

SANTA CLARA, Calif., May 9, 2023 /PRNewswire/ -- Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced that the Glassbeam Board of Directors has appointed Rhonda Longmore-Grund as Chairman of the Board, effective May 1, 2023. Rhonda is shifting to the Chairman role as Eric Milledge transitions to a Board Director position. "I feel very privileged to take on this role at Glassbeam given the challenges that the healthcare industry faces globally.  Glassbeam is providing innovative solutions that enable health systems, provide

SANTA CLARA, Calif., Dec. 1, 2022 /PRNewswire/ -- Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced that Rhonda Longmore-Grund will be joining the Board of Directors of Glassbeam. Ms. Longmore-Grund is the former President & CEO of Alliance Healthcare Services, a leading provider of comprehensive radiology and oncology services, partnering with over 1,000 hospitals across 46 states in the US to provide high quality, compassionate care to ~1 million patients each year. When Alliance was acquired in 2021 by Akumin Inc. (NASDAQ:AKU), Ms. Longmore-Grund served as President, Co-CEO and a Director of the newly merged Akumin/Alliance company

PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr

PLANTATION, Fla., June 30, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) (the "Company") held its annual general and special meeting of shareholders (the "Meeting") today, June 30, 2022, on a virtual meeting platform. A total 52,829,002 shares, representing approximately 59.0% of shares outstanding, were represented at the Meeting or by proxy at the Meeting. Further to TSX reporting requirements, the voting in relation to the election of directors was conducted at the Meeting and the results were as follows: Nominee Vote For# (%) Votes Withheld# (%) Not Voted # Thomas Davies 50,795,166 (99.93) 35,197 (0.07) 1,998,639 Stanley Dunford 50,795,366 (99.93) 34,997 (0.07) 1,998,639 Haichen

PLANTATION, Fla, May 13, 2021 /CNW/ - Akumin Inc. ("Akumin" or the "Corporation") (NASDAQ:AKU) (TSX:AKU) held its annual general and special meeting of shareholders (the "Meeting") today, May 13, 2021, on a virtual meeting platform. A total 47,315,152 shares, representing approximately 67.421% of shares outstanding, were represented at the meeting or by proxy at the meeting. Further to TSX reporting requirements, the voting in relation to the election of directors was conducted at the Meeting and the results were as follows: Nominee Votes For Votes Withheld Not Voted # (%) # (%) # Thomas Davies 45,687,401 (98.535%) 679,492 (1.465%) 948,259 Stan Dunford 46,365,418 (99.997%) 1,475 (0.003%) 948